Assignee
BIOCRYST PHARM INC
US·82 granted patents·30 pending applications·1,042 citations·filing 1994–2025
Top patents by PatentIndex Score
112 records- 0198US10662160B1Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2019·Granted May 26, 2020·17 cites·28 claims
- 0298US7560434B2AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jul 14, 2009·92 cites·29 claims
- 0397US12344585B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2023·Granted Jul 1, 2025·6 cites·12 claims
- 0497US11618733B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2021·Granted Apr 4, 2023·7 cites·16 claims
- 0597US11230530B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Jan 25, 2022·5 cites·22 claims
- 0697US11203574B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 21, 2021·5 cites·22 claims
- 0797US11192861B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 7, 2021·5 cites·27 claims
- 0897US11117867B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2020·Granted Sep 14, 2021·8 cites·20 claims
- 0997US10689346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 23, 2020·10 cites·38 claims
- 1097US10633345B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Apr 28, 2020·10 cites·25 claims
- 1197US10329260B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Jun 25, 2019·26 cites·45 claims
- 1297US10125102B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2015·Granted Nov 13, 2018·24 cites·16 claims
- 1397US7994139B2Antiviral therapeutic agentsBIOCRYST PHARM INC·Filed 2009·Granted Aug 9, 2011·81 cites·24 claims
- 1497US7429571B2Therapeutic furopyrimidines and thienopyrimidinesBIOCRYST PHARM INC·Filed 2006·Granted Sep 30, 2008·84 cites·16 claims
- 1596US11708333B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·23 claims
- 1696US11708332B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·16 claims
- 1796US11685721B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 27, 2023·2 cites·33 claims
- 1896US7514410B2Hepatitis C therapiesBIOCRYST PHARM INC·Filed 2006·Granted Apr 7, 2009·80 cites·42 claims
- 1996US7388002B2Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jun 17, 2008·39 cites·16 claims
- 2095US11708347B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·3 cites·9 claims
- 2195US11370774B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 28, 2022·4 cites·3 claims
- 2295US6699994B1Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2002·Granted Mar 2, 2004·87 cites·21 claims
- 2394US11866418B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jan 9, 2024·2 cites·17 claims
- 2494US2026092045A1Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2025·Application pending·0 cites
- 2593US12590069B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Mar 31, 2026·0 cites·30 claims
- 2693US12590068B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Mar 31, 2026·0 cites·30 claims
- 2793US12552750B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 17, 2026·0 cites·28 claims
- 2893US12545646B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 2993US12545645B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 3093US12545647B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 3193US11021458B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 1, 2021·5 cites·12 claims
- 3292US6653340B1Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparationBIOCRYST PHARM INC·Filed 1998·Granted Nov 25, 2003·88 cites·19 claims
- 3392US2025257040A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 3492US2025270171A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 3591US12043610B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jul 23, 2024·1 cites·9 claims
- 3691US11559515B2Indole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2020·Granted Jan 24, 2023·2 cites·19 claims
- 3791US6458799B1Deazaguanine analog, preparation thereof and use thereofBIOCRYST PHARM INC·Filed 2001·Granted Oct 1, 2002·36 cites·3 claims
- 3890US11173159B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2019·Granted Nov 16, 2021·3 cites·20 claims
- 3990US9492452B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2014·Granted Nov 15, 2016·9 cites·30 claims
- 4089US10420769B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2018·Granted Sep 24, 2019·4 cites·20 claims
- 4189US10022375B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2016·Granted Jul 17, 2018·5 cites·32 claims
- 4289US6936719B2Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2003·Granted Aug 30, 2005·37 cites·18 claims
- 4389US6656915B1Inhibiting T-cell proliferationBIOCRYST PHARM INC·Filed 2000·Granted Dec 2, 2003·47 cites·9 claims
- 4489US6503745B1Cyclopentane and cyclopentene compounds and use for detecting influenza virusBIOCRYST PHARM INC·Filed 1999·Granted Jan 7, 2003·42 cites·39 claims
- 4588US12162838B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Dec 10, 2024·0 cites·28 claims
- 4688US12116346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Oct 15, 2024·0 cites·26 claims
- 4787US10849883B2Benzopyrazole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2017·Granted Dec 1, 2020·3 cites·21 claims
- 4887US5602277ASubstituted benzene derivatives useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 1995·Granted Feb 11, 1997·33 cites·25 claims
- 4987US2025388545A1Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Application pending·0 cites
- 5086US11661426B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2018·Granted May 30, 2023·2 cites·42 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BIOCRYST PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →